Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Combining tacrolimus with excimer light is more effective for treating alopecia areata than using excimer light alone.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Baricitinib is effective and safe for treating severe alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

The combination of calcipotriol and PRP is the most effective treatment for alopecia areata.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Mini pulse corticosteroid therapy with oral dexamethasone is effective and has fewer side effects for treating extensive alopecia areata.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.